CORCORAN JESSI L 4

What Happened
Jessi L. Corcoran, Medline's Principal Accounting Officer, reported a purchase of 5,000 shares on 2026-06-05 at $34.15 per share, for a total transaction value of approximately $170,750. The filing reports a purchase (transaction code P), which is a direct acquisition of company stock rather than a sale.

Key Details

• Transaction date and price: 2026-06-05, 5,000 shares at $34.15 each (≈ $170,750).
• Filing date / timeliness: Form 4 filed 2026-06-09 — the filing appears late relative to the 2-business-day Form 4 deadline for insider trades.
• Shares owned after transaction: Not specified in the information provided.
• Transaction type / method: Reported as a purchase (P); described as "open market or private purchase" in the filing summary (method not explicitly clarified).
• Footnotes / plans: No 10b5-1 plan, tax withholding, or other special footnotes were indicated in the provided data.

Context
Insider purchases are often watched by retail investors as one signal of an insider adding to their position, but they are one data point among many — this summary is factual and does not infer motive. The late filing reduces the immediacy of the disclosure, which can matter for investors tracking timely insider activity.